Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2018
Claudio Alarcon, Ph.D.
Epitranscriptomic Regulation of Cancer Metastasis
Read More
2018
Russell Ryan, M.D.
Targeting BCL6 regulatory elements in ‘enhancer hijacking’ rearrangements *The research project that...
Read More
2018
Andrei Thomas-Tikhonenko, Ph.D.
Alternative surface epitopes in pediatric acute lymphoblastic leukemia
Read More
2018
Erica Stringer-Reasor, M.D.
PARP Inhibitors: A Novel Mechanism to Overcome Resistance in Aggressive HER2+ Breast...
Read More
2018
Elliot Stieglitz, M.D.
Precision Medicine in Juvenile Myelomonocytic Leukemia
Read More
2018
Frank Slack, Ph.D.
Biomarkers for a Phase I/II trial with anti-miR-155 in Diffuse Large B-cell...
Read More
2018
Michael Shen, Ph.D.
A co-clinical trial of chemotherapy response in bladder cancer using patient-derived tumor...
Read More
2018
Seth Pollack, M.D.
Transformation of the Synovial Sarcoma Tumor Microenvironment from Cold to Hot to...
Read More
2018
Markus Müschen, M.D., Ph.D.
Targeting Lgr5-mediated self-renewal and tumor-initiation in B-cell malignancies
Read More
2018
Roger Lo, M.D., Ph.D.
Pre-Clinical and Clinical Testing of Regimented Therapies for Mutant NRAS Melanoma
Read More
2018
Justin Kline, M.D.
PD-L1 gene amplifications and the “T cell inflamed” microenvironment in DLBCL
Read More
2018
Andras Heczey, M.D.
Genomic and functional characterization of CAR T cells in children with liver...
Read More
2018
Alan Friedman, M.D.
Adoptive Transfer of NF-kB p50 Deficient Myeloid Cells as Immunotherapy for Cancer
Read More
2018
James Brugarolas, M.D., Ph.D.
Directing Immunotherapy with iPET
Read More
2018
Yanis Boumber, M.D., Ph.D.
Biomarkers of combined PD1 and VEGFR2 blockade in metastatic NSCLC
Read More
2018
Nabeel Bardeesy, Ph.D.
Refined strategies to treat FGFR-driven cholangiocarcinoma
Read More